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Objective: The aim of our study was to conduct a systematic review with meta-analysis of the current case–
control studies about the valvular and pericardial involvement in patients with Rheumatoid Arthritis (RA),
asymptomatic for cardiovascular diseases.
Methods: Case–control studies were identiﬁed by searching PubMed (1975–2010) and the Cochrane Central
Register of Controlled Trials (CENTRAL) (1975–2010). Participants were adult patients with RA asymptomat-
ic for cardiovascular diseases, and the outcome measure was the presence of cardiac involvement.
Results: Quantitative synthesis included 10 relevant studies out of 2326 bibliographic citations that had been
found. RA resulted signiﬁcantly associated to pericardial effusion (OR 10.7; 95% CI 5.0–23.0), valvular nodules
(OR 12.5; 95% CI 2.8–55.4), tricuspidal valve insufﬁciency (OR 5.3; 95% CI 2.4–11.6), aortic valve stenosis (OR
5.2; 95% CI 1.1–24.1), mitral valve insufﬁciency (OR 3.4; 95% CI 1.7–6.7), aortic valve insufﬁciency (OR 1.7;
95% CI 1.0–2.7), combined valvular alterations (OR 4.3; 95% CI 2.3–8.0), mitral valve thickening and/or calci-
ﬁcation (OR 5.0; 95% CI 2.0–12.7), aortic valve thickening and/or calciﬁcation (OR 4.4; 95% CI 1.1–17.4), val-
vular thickening and/or calciﬁcation (OR 4.8; 95% CI 2.2–10.5), and mitral valve prolapse (OR 2.2; 95% CI 1.2–
4.0).
Conclusions: Our systematic review pointed out the strength and the grade of both pericardial and cardiac
valvular involvement in RA patients. Our ﬁndings underscore the importance of an echocardiographic assess-
ment at least in clinical research when RA patients are involved. Moreover, further research is needed to un-
derstand the possible relationship of our ﬁndings and the increased cardiovascular mortality.© 2012 Elsevier Ireland Ltd. All rights reserved.1. Introduction
Rheumatoid Arthritis (RA) is a chronic inﬂammatory disease that af-
fects joints causing deformities, severe disability and premature mortal-
ity [1,2]. This disease has a high social and economic burden. Indeed,
about 1.3 million adults are affected by RA in the United States [3]. The
world prevalence of RA might be around 0.3–1.2% [4]. Recently the
Swedish patients register [5] has shown a RA cumulative prevalence of
0.77% (women 1.16%men 0.44%) conﬁrming abovementioned assump-
tions. In this disease, the synovialmembrane is themain target, althoughl support of University of Paler-
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eart involvement in Rheumextra-articular manifestations can be found including the cardiac ones.
Pericarditis is the cardiac manifestation most readily recognized, but
myocardial disease, coronary vasculitis, diastolic dysfunction, accelerat-
ed atherosclerosis and valvular lesions of the heart have also been
reported [6]. The premature mortality among patients with RA is fre-
quently due to cardiovascular disease [7], primarily ischemic heart dis-
ease [8] and congestive heart failure [9]. A recent meta-analysis of our
team showed that rheumatoid patients have a higher left ventricular
mass than controls [10]. Moreover, in rheumatoid patients without
overt cardiovascular disease, we previously reported pericardial, valvu-
lar, and aortic root involvement that we clinically deﬁned as “silent
rheumatoid heart disease” [11]. Recently, Yiu et al. [12] have found out
a signiﬁcant association between Rheumatoid Arthritis and valvular cal-
ciﬁcations. This study used multidetector computed tomography and
has also pointed out that the presence of mitral valve calciﬁcation inde-
pendently predicted the occurrence of premature atherosclerosis. On
the other hand, several echocardiographic studies have been published
in the last two decades on this issue. So that, summarizing evidence
from all these studies may be useful to understand the effect of theatoid Arthritis: Systematic review and meta-analysis, Int J Cardiol
Fig. 1. Systematic review ﬂow diagram according to the MOOSE standard: the ﬂow
chart shows the selection process regarding the retrieved citations; trials on treatment
and studies not pertinent were excluded such as all the studies that were not con-
trolled ones.
2 S. Corrao et al. / International Journal of Cardiology xxx (2012) xxx–xxxdisease on cardiac structures of rheumatoid patients almost partially in
the pre-biological era.
The aim of our study was to perform a systematic review and
meta-analysis of the current case–control studies based on echocar-
diographic assessment of valvular and pericardial involvement in pa-
tients with RA.
2. Materials and methods
2.1. Search strategy for identiﬁcation of studies
The review was achieved following the Cochrane Collaboration Steps [13] and the
Meta-analysis of Observational Studies in Epidemiology (MOOSE) standard of reporting
[14].
Sources of published data included electronic database such as PubMed-Medline
(1975–July 2010) [15] and the Cochrane Central Register of Controlled Trials (CENTRAL)
(1975–July 2010) [16]. The search strategy was as follows: “rheumatoid arthritis AND
(heart OR ventricle ORventricular OR valvular)”without any other restriction for reaching
maximum recall. We controlled for the terms “pericardial or pericardium” but it did not
add any further citation recall compared to the above mentioned search string.
2.2. Criteria for considering studies for this review
Retrieved citations were screened independently by two adjudicators (SC, SM) using
titles of papers and abstracts. Once pertinent studies (that is according to the aim of this
systematic review) were identiﬁed, the full publication was retrieved and reviewed inde-
pendently by the two investigators to determine the suitability for ﬁnal inclusion.
The reviewers were blinded to the names of authors, institutions or journals, and
articles were independently selected for inclusion according to the prespeciﬁed selec-
tion criteria. No prejudice in study evaluation was made.
The type of studies considered to be included was controlled clinical trial with
case–control design. Series of case, descriptive reports, cohort and uncontrolled studies
were excluded from the analysis. Participants in the studies were adult patients with
RA, asymptomatic for cardiovascular diseases.
Measured outcome was the proportion of patients with valvular and pericardial
involvement.
2.3. Quality assessments
Methodological quality was assessed independently by two reviewers (SC, SM)
using the STROBE (Strengthening the Reporting of Observational studies in Epidemiol-
ogy Statement) recommendations [17], with special consideration on selection bias
and detection bias. Performance bias was not considered because it concerns pharma-
cological studies. Moreover, loss to follow-up was not considered basing on the design
of the included studies in this review (only case–control ones).
2.4. Data extraction and statistical analysis
Data on patients, methods, outcomes and results were extracted using a data extrac-
tion form (SM, LC). Disagreement was resolved by other adjudicator (SC). Data were an-
alyzed using the STATA Version 9.0 and were presented as odds ratio (OR) along with
their corresponding 95% conﬁdence intervals (CI). Heterogeneity was investigated by
using the I2 statistic with signiﬁcance set at pb0.05. Pooled ORs and 95% CIswere calculat-
ed using a random effect model or a ﬁxed effect model according to heterogeneity. Bias of
publication was evaluated by the Egger Regression Asymmetry Test and the Regression
Asymmetry Plot.
3. Results
The search string that we used recalled 2326 bibliographic citations.
Theywere screened, and55paperswere retrievedbecause theywere rec-
ognized as pertinent. Then, 16 studies were excluded because they were
not case–control studies, 1 because it was a pharmacological study and
28 because they were not pertinent. So we identiﬁed 10 relevant papers.
All of them were used for this systematic review. All the patients were
asymptomatic for cardiovascular disease, and, after echocardiographic as-
sessment, none was reported affected by more than slight–moderate
hemodynamic valvular alterations (as regurgitation as stenosis). Fig. 1
shows the ﬂow-diagram of the study selection process. Appendix 1
shows characteristics of studies that were included in this systematic re-
view [11,18–26]. Appendix 2 shows the list of studies thatwere excluded.
We performed a meta-analysis for each of the following abnormali-
ties: pericardial effusion, valvular nodules, valvular thickening and/or
calciﬁcation (Fig. 2), tricuspidal valve insufﬁciency, aortic valve insufﬁ-
ciency, aortic valve stenosis, mitral valve stenosis, mitral valve prolapsePlease cite this article as: Corrao S, et al, Heart involvement in Rheum
(2012), doi:10.1016/j.ijcard.2012.05.057(Fig. 3), and combined valvular alterations (Fig. 4). Fig. 5 shows other
four meta-analyses that were preformed about mitral valve thicken-
ing/calciﬁcation, aortic valve thickening/calciﬁcation, mitral valve pro-
lapse, and mitral valve insufﬁciency. Pulmonary valve insufﬁciency
and aortic valve prolapse were reported by only one study [18]. Thus,
in this case, we did not perform any meta-analysis.
Theﬁxedmodelwas used for the following abnormalities: pericardi-
al effusion, valvular nodules, valvular thickening and/or calciﬁcation,
tricuspidal valve insufﬁciency, aortic valve insufﬁciency, aortic valve
stenosis, mitral valve stenosis, and combined valvular alterations.
The random model was used for the following abnormalities: mi-
tral valve insufﬁciency, mitral valve thickening and/or calciﬁcation,
aortic valve thickening and/or calciﬁcation.
We preferred to use ﬁxed and random models for mitral valve
prolapse since the high I2 (51.8%; pb0.081) even if not signiﬁcant.
Table 1 shows the summary data of all the performedmeta-analyses,
including the Egger's test statistic for evaluation of the publication bias.
Only in the case of aortic valve stenosis, we found a signiﬁcant p value by
the Egger's test (this test states a probable publication bias in this ﬁeld of
knowledge).
Our meta-analyses showed a higher risk of pericardial effusion and
valvular nodules more than ten times in patients with RA compared
with controls. Concerning data about tricuspidal valve insufﬁciency, aortic
valve stenosis, and mitral valve thickening/calciﬁcation, meta-analyses
showed an increased risk about ﬁve timesmore in patients with RA com-
paredwith controls. Moreover, data about valvular thickening and/or cal-
ciﬁcation, combined valvular alterations, and aortic valve thickening and/
or calciﬁcation showed an increased risk about four times in patientswith
RA comparedwith controls. Data aboutmitral valve insufﬁciency showed
an increased risk about three times in patients with RA compared with
controls. A risk about twice in patients with RA compared with controls
emerged from data about aortic valve insufﬁciency. Finally, data of
meta-analyses did not show an increased risk aboutmitral valve stenosis,atoid Arthritis: Systematic review and meta-analysis, Int J Cardiol
Fig. 2. Forest plot summarizing meta-analyses of pericardial effusion, valvular nodules and valvular thickening and/or calciﬁcation; the pooled odds ratios, represented by the di-
amonds, show a higher risk, in RA patients, of pericardial effusion, valvular nodules and valvular thickening and/or calciﬁcation (all the diamonds are on the right side to the equal-
ity line).
3S. Corrao et al. / International Journal of Cardiology xxx (2012) xxx–xxx[OR (95%CI): 2.1 (0.7–6.9); p=0.199], pulmonary valve insufﬁciency [OR
(95% CI): 3.1 (0.1–79.2); p=0.494], and aortic valve prolapse [OR (95%
CI): 2.1(0.2–24.1); p=0.561] in patients with RA compared withFig. 3. Forest plot summarizing meta-analyses of tricuspidal valve insufﬁciency, aortic valve
pooled odds ratios, represented by the diamonds, show a higher risk, in RA patients, of tricu
RA patients than controls such as the risk of mitral valve prolapse (however in this last case
the same meta-analysis on mitral valve prolapse applying the random-effect model).
Please cite this article as: Corrao S, et al, Heart involvement in Rheum
(2012), doi:10.1016/j.ijcard.2012.05.057controls. About mitral valve prolapse, the meta-analysis showed a high
grade of heterogeneity (I2=51.8%) even though it did not result signiﬁ-
cant [OR (95% CI): 2.2(0.8–6.1); p=0.081]: in this case, we performed ainsufﬁciency, aortic valve stenosis, mitral valve stenosis and mitral valve prolapse; the
spidal and aortic valve regurgitation; the risk of aortic valve stenosis resulted higher in
the I-squared resulted large even though not signiﬁcant for heterogeneity; see Fig. 5 for
atoid Arthritis: Systematic review and meta-analysis, Int J Cardiol
Fig. 4. Forest plot of combined valvular alteration; the pooled odds ratio, represented
by the diamond, shows a higher risk, in RA patients, of combined valvular alteration
(the diamond is on the right side to the equality line).
4 S. Corrao et al. / International Journal of Cardiology xxx (2012) xxx–xxxsensitive analysis using both the models (ﬁxed and random); the two
analyses showed different results with a potentially double risk in pa-
tients with RA compared with controls (Table 1).4. Discussion
Various signiﬁcant cardiac alterations have been detected by echo-
cardiography in RA patient with no cardiac symptoms and/or clinical
evidence of extra cardiac complaints. The extra-articular inﬂammatory
process seems to involve the pericardium frequently and insidiously,
even in the absence of symptoms. In fact, pericardial effusion is the
most frequent abnormality, and it has been described as minimal peri-
cardial effusion (end-diastolic pericardial–epicardial separation up toFig. 5. Forest plot summarizing meta-analyses of mitral prolapse, mitral valve insufﬁciency
cation; the pooled odds ratios, represented by the diamonds, show a higher risk, in RA patie
valve thickening and/or calciﬁcation except for mitral valve prolapse (note that in this plo
studies did not result to a statistical signiﬁcance; see Fig. 3 for the same meta-analysis on m
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(2012), doi:10.1016/j.ijcard.2012.05.0574 mm) or overt pericardial effusion (end-diastolic pericardial–epicardi-
al separation more than 4 mm) [11].
The other main alterations are mitral and aortic valve thickening,
mitral valve prolapsewith or without insufﬁciency, isolated valvular in-
sufﬁciency and aortic root abnormalities [11], (i.e. enlargement of al-
most one sinus of Valsalva). Abnormal valve echoes in RA patients
might be due to ﬁbrosis of the valve structures for extra-articular in-
ﬂammatory process [11]. Beyond these valvular alterations, left ventric-
ular diastolicﬁlling abnormalities have been observed in spite of normal
left ventricular systolic function. This might be clinically very important
because diastolic dysfunction has been recognized as a primary cause of
congestive heart failure that is highly prevalent in RA patients. In these
patients, diastolic dysfunction seems to be related with structural ab-
normalities of the left ventricle, in particular with changes regarding
left ventricular mass, interventricular septum thickening and posterior
wall thickening [27]. Also, Rudominer et al., in a recent study, have de-
scribed the association between AR and an increased left ventricular
mass [28], and this increase has been conﬁrmed by our recent meta-
analysis [10].
Thus, ﬁve alterations at least seem to be typical of RA patientswithout
any symptom of cardiac disease: 1) pericardial effusion, 2) valvular thick-
ening and nodules, 3) isolated valvular insufﬁciency, 4) aortic root alter-
ation, and 5) structural (increased left ventricular mass) and functional
(diastolic dysfunction) left ventricular changes. These changes are vari-
ously combined in each patient. Hence, we believed that it is possible to
represent this heart involvement such as “silent rheumatoid heart dis-
ease”. On the other hand, abnormalities in left ventricular myocardial
structure and diastolic function are clinically very important. Indeed,
these abnormalities are also correlated to a higher risk of both cardiac fail-
ure and cardiovascular mortality in patients with RA. However, these, mitral valve thickening and/or calciﬁcation and aortic valve thickening and/or calciﬁ-
nts, of mitral valve insufﬁciency, mitral valve thickening and/or calciﬁcation and aortic
t the random effect model was applied even though heterogeneity for all the included
itral valve prolapse applying the ﬁxed-effect model).
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Table 1
Summary data of all the performed meta-analyses. Odds ratios (ORs) and their 95% conﬁdence intervals, p values concerning statistical signiﬁcance of ORs, the I2 statistic, p values
concerning heterogeneity, and p values of the Egger's test are shown. The Egger's test represents the statistic to evaluate publication bias.
Ecocardiographic abnormalities Pooled ORa (95% CIb) p I2c (%) p (heterogeneity) Egger's testd
p
Pericardial effusion 10.698 (4.969–23.033) 0.000 0.0 0.656 0.746
Valvular nodules 12.518 (2.828–55.404) 0.001 0.0 0.931 0.283
Valvular thickening and/or calciﬁcation 4.773 (2.163–10.534) 0.000 18.1 0.300 0.702
Mitral valve insufﬁciency 3.369 (1.691–6.710) 0.001 66.1 0.003 0.178
Tricuspidal valve insufﬁciency 5.265 (2.388–11.609) 0.000 0.0 0.882 0.727
Aortic valve insufﬁciency 1.673 (1.036–2.703) 0.035 0.0 0.976 0.069
Pulmonary valve insufﬁciencye 3.102 (0.121–79.228) 0.494 n.a.f n.a.f n.a.f
Aortic valve stenosis 5.249 (1.140–24.165) 0.033 0.0 0.952 0.009
Mitral valve stenosis 2.151 (0.669–6.916) 0.199 0.0 0.775 0.153
Mitral valve prolapse (ﬁxed effect model) 2.208 (1.200–4.065) 0.011 51.8 0.081 0.613
Mitral valve prolapse (random effect model) 2.241 (0.825–6.091) 0.114 51.8 0.081 0.613
Aortic valve prolapsee 2.071 (0.178–24.148) 0.561 n.a.f n.a.f n.a.f
Combined valvular alterations 4.303 (2.310–8.018) 0.000 26.8 0.243 0.552
Mitral valve thickening and/or calciﬁcation 5.038 (2.002–12.680) 0.001 63.4 0.018 0.182
Aortic valve thickening and/or calciﬁcation 4.386 (1.104–17.430) 0.036 74.4 0.004 0.212
a OR: odds ratio.
b CI = conﬁdence interval.
c I2 = as a measure of statistical heterogeneity.
d Egger's test for publication bias.
e Only one study was recognized.
f n.a. = not assessable.
5S. Corrao et al. / International Journal of Cardiology xxx (2012) xxx–xxxaspects related to the left ventricle structure and function, although very
important, were not the object of this systematic review, but further in-
vestigation about this issue is hoped for completing the whole picture
of the heart involvement in RA.
The results of this systematic reviewwith meta-analysis have shown
some unclear areas of literature about pulmonary valve insufﬁciency and
aortic valve prolapse (investigated by only one study), and aortic valve
stenosis (publication bias was detected). Another gray zone regards mi-
tral valve prolapse. Indeed, we found an intermediate grade of heteroge-
neity that involved contrasting results when different meta-analysis
models were applied. While, according to the ﬁndings of this systematic
review, data are substantially strong concerning an increased risk of both
pericardial involvement and aortic and mitral valvular alterations in RA
patients compared to healthy controls. In particular, there was a strong
evidence of pericardial effusion and mitral or aortic regurgitation as
well as valvular nodules and isolated or combined valvular thickening/
calciﬁcations. Moreover, our systematic review ﬁts with clinical studies
recruiting patients mainly followed-up in the pre-biological drug era.
This represents a chance to evaluate actual effects on the heart of the un-
derlying phlogistic rheumatoid process without shadowing by the pow-
erful biological drugs. On the other hand, the paramount importance of
our ﬁndings lies in the fact that the presence of aortic andmitral valvular
calciﬁcations has been associated with cardiovascular events in the gen-
eral population [29,30]. Indeed, Yiu et al. recently [12] demonstrated that
cardiac valvular calciﬁcations in patients with RA and Systemic LupusAuthor,
publication
year, country
Design Study's objective Parti
Beckhauser
AP et al.
2009, Brazil
Case–
control
To verify the frequency of valvular heart involvement
in Rheumatoid Arthritis patients by trans-thoracic
echocardiographic examination.
184
(17
disea
122
Wislowska M
et al. 2008,
Poland
Case–
control
To assess systolic and diastolic function of the left
ventricle in Rheumatoid Arthritis patients, by
trans-thoracic echocardiographic examination, and
also estimate whether there is a correlation between the
duration and severity of Rheumatoid Arthritis and
the degree of left ventricle diastolic dysfunction.
30 rh
(5 m
from
30 co
Appendix 1. Characteristics of the studies included in the quantitative sy
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(2012), doi:10.1016/j.ijcard.2012.05.057Erythematosus predict the occurrence of premature atherosclerosis
with arterial calciﬁcation. For the ﬁrst time, our systematic review has
documented the grade and strength of the association between pericar-
dial and cardiac valvular alterations, in particular valvular calciﬁcations,
and RA. These ﬁndings could be very useful for further research that
would explain the highest cardiovascular morbidity and mortality in
this kind of patients.
In conclusion, we found a signiﬁcant valvular and pericardial involve-
ment in RA patients compared with control samples. All seems to repre-
sent the cardiac expression of the same underlying phlogistic process
typical of RA disease. This should be considered a cornerstone for future
research in the ﬁeld of RA where echocardiographic assessment should
be considered as part of the instrumental assessment of the recruited pa-
tients. However, further research is needed to understand the possible re-
lationship of our ﬁndings and the increased cardiovascular mortality in
this kind of patients. Finally, we think that the knowledge of presence
andkind of unrecognized cardiac abnormalities in asymptomatic patients
might be important for the correct management of RA patients.Acknowledgment
The authors of this manuscript have certiﬁed that they comply
with the Principles of Ethical Publishing in the International Journal
of Cardiology [31].cipants
rheumatoid patients
men, 167 women; mean age 48.2±13.9 yrs; mean duration of
se 8.4±7.4 yrs) from the Rheumatology Unit of Hospital Evangelico de Curtiba;
controls (18 men, 104 women; mean age 51.5±14.4 yrs).
eumatoid patients
en, 25 women; mean age 51.8±7.6 yrs; mean duration of disease 12.5±9.3 yrs)
the Rheumatologic Outpatient Department of the central clinical hospital in Warsaw;
ntrols (5 men, 25 women; mean age 51.7±7.6 yrs).
nthesis
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Author,
publication
year, country
Design Study's objective Participants
Roldan CA et
al. 2007,
New Mexico
Case–
control
To characterize valvular heart disease associated
with Rheumatoid Arthritis by trans-esophageal
echocardiography.
34 rheumatoid patients
(15 men, 19 women; mean age 50±10 yrs; mean duration of disease 13±7 yrs)
from the University of New Mexico Health Science Center in Albuquerque;
34 controls (16 men, 18 women; mean age 42±6 yrs).
Kamiński G
et al. 2005,
Poland
Case–
control
To assess the effect of rheumatoid process on the
heart in patients with Rheumatoid Arthritis without
clinically over features of heart disease by trans-
thoracic echocardiographic examination.
50 rheumatoid patients
(6 men, 44 women; mean age 59.4±11.1 yrs; mean duration of disease 10.7±8.7 yrs)
in Warsaw;
50 controls (6 men, 44 women; mean age 59.2±11.2 yrs).
Gonzalez‐
Juanatey C
et al. 2004,
Spain
Case–
control
To assess the frequency of structural and functional
abnormalities in long-term treated Rheumatoid
Arthritis patients without clinically evident
cardiovascular manifestation, by trans-thoracic
echocardiographic examination.
47 rheumatoid patients
(11 men, 35 women; mean age 59.2±12.5 yrs; mean duration of disease 15.5±8.5 yrs)
from the Hospital Xeral-Calde, Lugo, in Northwest Spain;
47 controls (11 men, 36 women; mean age 58.6±12.4 yrs).
Guedes C et al.
2001, France
Case–
control
To assess the frequency and type of heart lesions in
Rheumatoid Arthritis, coupling trans-thoracic
echocardiography with trans-esophageal one.
30 rheumatoid patients
(4 men, 26 women; mean age 57.8±15.1 yrs; mean duration of disease 11±8.7 yrs)
from the Rheumatology Department of the Bobigny-Avicenne Teaching Hospital, France;
30 controls (4 men, 26 women; mean age 57.8±15.0 yrs).
Wislowka M
et al. 1999,
Poland
Case–
control
To assess cardiac abnormalities in two groups of
Rheumatoid Arthritis patients, nodular and non
nodular, by trans-thoracic echocardiographic
examination.
35 nodular rheumatoid patients and 35 non nodular ones
(14 men, 56 women; mean age 53.4±9.4 yrs; mean duration of disease 9.4±6.7 yrs)
from the Rheumatology Outpatient Department of the Central Clinical Hospital
in Warsaw;
35 controls with osteoarthrosis and spondyloarthrosis (7 men, 28 women;
mean age 53.3±9.4 yrs).
Wislowska M
et al. 1998,
Poland
Case–
control
To assess cardiac abnormalities in Rheumatoid
Arthritis patients by echocardiographic examination.
100 rheumatoid patients
(18 men, 82 women; mean age 49.9±11.3 yrs; mean duration of disease 9.4±6.7 yrs)
from the Rheumatology Outpatient Department of the Central Clinical Hospital
in Warsaw;
100 controls with osteoarthrosis (n.8) and spondyloarthrosis (n.92)
(18 men, 82 women; mean age 49.8±11.1 yrs).
Tlustochowicz
W et al. 1997,
Poland
Case–
control
To assess the clinical signiﬁcance of heart lesions in
Rheumatoid Arthritis patients by trans-thoracic
echocardiographic examination.
100 rheumatoid patients
(23 men, 77 women; mean age 55.7±12.5 yrs; mean duration of disease 8.3±8.0 yrs)
from the University Hospital of Warsaw;
100 controls (23 men, 77 women; mean age 55.7±12.7 yrs).
Corrao S et al.
1995, Italy
Case–
control
To determine the nature and extent of cardiac
involvement in Rheumatoid Arthritis patients with
no symptoms of cardiac disease by trans-thoracic
echocardiographic examination.
35 rheumatoid patients
(5 men, 25 women; mean age 51±11 yrs; mean duration of disease 5±8 yrs)
from Rheumatological outpatient clinic in Palermo;
52 controls (7 men, 45 women, mean age 51±12 yrs).
Author, publication year Title Reason of
exclusion
1 Berisha I, Berisha B, Krasniqi X, 2010 Cardiac and pulmonary alterations in patients with Rheumatoid Arthritis. Not case–control
study
2 Obradović‐Tomasević B, Vujasinović‐Stupar N,
Tomasević R, 2009
The assessment of diastolic function in patients with Rheumatoid Arthritis. Not case–control
study
3 Sugiura T, Kumon Y, Kataoka H, Matsumura Y, Takeuchi H,
Doi Y, 2008
Asymptomatic pericardial effusion in patients with Rheumatoid Arthritis. Not case–control
study
4 Dawson JK, Goodson NG, Graham DR, Lynch MP, 2000 Raised pulmonary artery pressures measured with Doppler echocardiography
in Rheumatoid Arthritis patients.
Not case–control
study
5 Nemchinov EN, Kanevskaia MZ, Chichasova NV, Telepneva LM,
Krel' AA, 1994
Heart defects in Rheumatoid Arthritis patients (the results of a multiyear
prospective clinico-echocardiographic study).
Not case–control
study
6 Rowe IF, Gibson DG, Keat AC, Brewerton DA, 1991 Echocardiographic diastolic abnormalities of the left ventricle in inﬂammatory
joint disease.
Not case–control
study
7 Kelly CA, Bourke JP, Malcolm A, Grifﬁths ID, 1990 Chronic pericardial disease in patients with Rheumatoid Arthritis: a longitudinal
study.
Not case–control
study
8 Mody GM, Stevens JE, Meyers OL, 1987 The heart in Rheumatoid Arthritis: a clinical and echocardiographic study. Not case–control
study
9 Badui E, Jiménez J, Saldivar C, Mintz G, Lavalle C, Fraga A, 1987 The heart and Rheumatoid Arthritis. Prospective study of 100 cases. Not case–control
study
10 Kozáková M, Hradec J, Petrásek J, Kölbel F, Urbanová M,
Dostál C, 1985
Cardiac involvement in progressive polyarthritis: an echocardiographic study. Not case–control
study
11 Svantesson H, Björkhem G, Elborgh R, 1983 Cardiac involvement in juvenile Rheumatoid Arthritis. A follow-up study. Not case–control
study
12 Nomeir AM, Turner RA, Watts LE, 1979 Cardiac involvement in Rheumatoid Arthritis. Follow‐up study. Not case–control
study
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(continued)
Author, publication year Title Reason of
exclusion
13 Devlin AB, Goldstraw P, Caves PK, 1978 Aortic valve replacement in rheumatoid aortic incompetence. Not case–control
study
14 David-Chaussé J, Blanchot P, Warin J, Dehais J, Bullier R,
Texier JM, 1976
Atrioventricular blocks and Rheumatoid Arthritis. Not case–control
study
15 Thadani U, Iveson JM, Wright V, 1975 Cardiac tamponade, constrictive pericarditis and pericardial resection in
Rheumatoid Arthritis.
Not case–control
study
16 Okada T, Shiokawa Y, 1975 Cardiac lesions in collagen disease. Not case–control
study
17 Ikonomidis I, Lekakis JP, Nikolaou M, Paraskevaidis I,
Andreadou I, Kaplanoglou T, Katsimbri P, Skarantavos G,
Soucacos PN, Kremastinos DT, 2008
Inhibition of interleukin-1 by anakinra improves vascular and left ventricular
function in patients with Rheumatoid Arthritis.
Pharmacological
study
18 Liang KP, Myasoedova E, Crowson CS, Davis JM, Roger VL,
Karon BL, Borgeson DD, Therneau TM, Rodeheffer RJ,
Gabriel SE, 2010
Increased prevalence of diastolic dysfunction in Rheumatoid Arthritis. Not pertinent
19 Rudominer RL, Roman MJ, Devereux RB, Paget SA,
Schwartz JE, Lockshin MD, Crow MK, Sammaritano L,
Levine DM, Salmon JE, 2009
Independent association of Rheumatoid Arthritis with increased left
ventricular mass but not with reduced ejection fraction.
Not pertinent
20 Yavasoglu I, Senturk T, Onbasili A, 2008 Diastolic dysfunction in Rheumatoid Arthritis and duration of disease. Not pertinent
21 Yazici D, Tokay S, Aydin S, Toprak A, Inanc N, Khan SR,
Fak AS, Direskeneli H, 2008
Echocardiographic evaluation of cardiac diastolic function in patients with
Rheumatoid Arthritis: 5 years of follow-up.
Not pertinent
22 Meune C, Wahbi K, Assous N, Weber S, Kahan A,
Allanore Y, 2007
Myocardial dysfunction in Rheumatoid Arthritis: a controlled tissue-Doppler
echocardiography study.
Not pertinent
23 Udayakumar N, Venkatesan S, Rajendiran C, 2007 Diastolic function abnormalities in Rheumatoid Arthritis: relation with
duration of disease.
Not pertinent
24 Birdane A, Korkmaz C, Ata N, Cavusoglu Y, Kasifoglu T,
Dogan SM, Gorenek B, Goktekin O, Unalir A,
Timuralp B, 2007
Tissue Doppler imaging in the evaluation of the left and right ventricular
diastolic functions in Rheumatoid Arthritis.
Not pertinent
25 Guler H, Seyfeli E, Sahin G, Duru M, Akgul F, Saglam H,
Yalcin F, 2007
P wave dispersion in patients with Rheumatoid Arthritis: its relation with
clinical and echocardiographic parameters.
Not pertinent
26 Krasnosel'skĭ MIa, Bratanova MZ, Polupan AA,
Tsurko VV, 2007
Tissue dopplerography of the myocardium in diagnosis of myocardial
involvement in patients with Rheumatoid Arthritis.
Not pertinent
27 Nemchinov EN, 2006 The functional condition of the left ventricle in patients suffering from
Rheumatoid Arthritis with subcutaneous rheumatoid nodules.
Not pertinent
28 Rexhepaj N, Bajraktari G, Berisha I, Beqiri A, Shatri F, Hima F,
Elezi S, Ndrepepa G, 2006
Left and right ventricular diastolic functions in patients with Rheumatoid
Arthritis without clinically evident cardiovascular disease.
Not pertinent
29 Seyfeli E, Guler H, Akoglu S, Karazincir S, Akgul F, Saglam H,
Seydaliyeva T, Yalcin F, 2006
Right ventricular diastolic abnormalities in Rheumatoid Arthritis and its
relationship with left ventricular and pulmonary involvement. A tissue
Doppler echocardiographic study.
Not pertinent
30 Canturk F, Yazici M, Alayli G, Menekse EB, Demircan S,
Ibrahimli F, Menekse S, 2006
Combined use of propagation velocity and intraventricular dispersion of E
wave velocity for the evaluation of diastolic functions in patients with
Rheumatoid Arthritis.
Not pertinent
31 Arslan S, Bozkurt E, Sari RA, Erol MK, 2006 Diastolic function abnormalities in active Rheumatoid Arthritis evaluation by
conventional Doppler and tissue Doppler: relation with duration of disease.
Not pertinent
32 Arslan S, Bozkurt E, Sari RA, Erol MK, 2006 Use of tissue Doppler and its comparison with other conventional Doppler
techniques in the assessment of diastolic functions in patients with active
Rheumatoid Arthritis.
Not pertinent
33 Bharti BB, Kumar S, Kapoor A, Agarwal A, Mishra R,
Sinha N, 2004
Assessment of left ventricular systolic and diastolic function in juvenile
Rheumatoid Arthritis.
Not pertinent
34 Yildiz M, Soy M, Kurum T, Ozbay G, 2004 Increased pulse wave velocity and shortened pulse wave propagation time in
young patients with Rheumatoid Arthritis.
Not pertinent
35 Levendoglu F, Temizhan A, Ugurlu H, Ozdemir A,
Yazici M, 2004
Ventricular function abnormalities in active Rheumatoid Arthritis: a Doppler
echocardiographic study.
Not pertinent
36 Kamiński G, Cholewa M, Tłustochowicz W, Cwetsch A,
Skrobowski A, Dziuk M, 2003
Left ventricular function in Rheumatoid Arthritis patients. Not pertinent
37 Alpaslan M, Onrat E, Evcik D, 2003 Doppler echocardiographic evaluation of ventricular function in patients with
Rheumatoid Arthritis.
Not pertinent
38 Klocke R, Cockcroft JR, Taylor GJ, Hall IR, Blake DR, 2003 Arterial stiffness and central blood pressure, as determined by pulse wave
analysis, in Rheumatoid Arthritis.
Not pertinent
39 Oguz D, Ocal B, Ertan U, Narin H, Karademir S,
Senocak F, 2000
Left ventricular diastolic functions in juvenile Rheumatoid Arthritis. Not pertinent
40 Di Franco M, Paradiso M, Mammarella A, Paoletti V,
Labbadia G, Coppotelli L,Taccari E, Musca A, 2000
Diastolic function abnormalities in Rheumatoid Arthritis. Evaluation by echo
Doppler transmitral ﬂow and pulmonary venous ﬂow: relation with duration
of disease.
Not pertinent
41 Montecucco C, Gobbi G, Perlini S, Rossi S, Grandi AM,
Caporali R, Finardi G, 1999
Impaired diastolic function in active Rheumatoid Arthritis. Relationship with
disease duration.
Not pertinent
42 Corrao S, Sallì L, Arnone S, Scaglione R, Pinto A,
Licata G, 2006
Echo-Doppler left ventricular ﬁlling abnormalities in patients with
Rheumatoid Arthritis without clinically evident cardiovascular disease.
Not pertinent
43 Tłustochowicz W, Piotrowicz R, Cwetsch A, Raczka A,
Kramarz E, Nowak J, 1995
24-h ECG monitoring in patients with Rheumatoid Arthritis. Not pertinent
44 Mustonen J, Laakso M, Hirvonen T, Mutru O, Pirnes M,
Vainio P, Kuikka JT, Rautio P, Länsimies E, 1993
Abnormalities in left ventricular diastolic function in male patients with
Rheumatoid Arthritis without clinically evident cardiovascular disease.
Not pertinent
45 Del Real-More O, Villavicencio R, Iglesias-Gamarra A,
Pena MA, Cueto L, Arriaga-Gracia J,
Alarcon-Segovia D, 1983
Echocardiographic evaluation of patients with Rheumatoid Arthritis. Not pertinent
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